Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Nektar Therapeutics Stock Surge: Shares of Nektar Therapeutics rose 30.3% in pre-market trading after announcing the release date for top-line data from its Phase 2b REZOLVE-AD clinical trial on June 24, 2025.
Market Movements: Several stocks experienced significant pre-market movements, with iBio, Inc. gaining 55.8% and Upexi, Inc. dropping 62.3%, reflecting a mix of gains and losses across various companies.
Trade with 70% Backtested Accuracy
Analyst Views on UPXI
About UPXI
About the author

- Conference Details: Brian Rudick, Chief Strategy Officer of Upexi, Inc., will present at the LD Micro Invitational XVI Conference on May 19, 2026, at 2:00 PM at the Luxe Sunset Boulevard Hotel in Los Angeles, aiming to attract investor interest in the company's strategic initiatives.
- Digital Asset Strategy: Upexi focuses on acquiring and holding Solana (SOL) in a disciplined manner, currently holding over 2 million SOL, leveraging intelligent capital issuance, staking, and discounted locked token purchases to enhance value accrual, showcasing its competitive edge in the digital asset space.
- Risk Management: The company operates in a risk-prudent manner to adapt to various market environments, aiming to appeal to a diverse range of investors, thereby strengthening its market position and investment appeal.
- Brand Development: In addition to digital assets, Upexi specializes in the development, manufacturing, and distribution of consumer products, demonstrating its diversified business model and market expansion capabilities.
- Repurchase Program Update: As of May 5, 2026, Upexi has repurchased a total of 2,894,287 shares, with $47,226,036 remaining in its share repurchase program, demonstrating the company's ongoing commitment to enhancing shareholder value.
- Annual Repurchase Data: In February and March 2026, the company repurchased 1,637,500 and 840,561 shares at average prices of $0.76 and $0.87 per share, indicating a proactive capital management strategy amid market fluctuations.
- Maximizing Shareholder Value: Management plans to provide periodic updates on the repurchase program through press releases and financial reports, aiming to maximize shareholder value through repurchases and other available tools to bolster investor confidence.
- Digital Asset Strategy: Upexi focuses on acquiring and holding Solana (SOL) in a disciplined and accretive manner, currently holding approximately 2.4 million SOL, utilizing mechanisms such as intelligent capital issuance, staking, and discounted locked token purchases to showcase its strategic positioning in the digital asset space.
Update on Share Repurchase Program: UPEX IPR provides a periodic update regarding its share repurchase program, indicating ongoing commitment to returning value to shareholders.
Details of the Program: The update includes specifics about the number of shares repurchased and the financial implications for the company, reflecting its strategic financial management.
- Earnings Call Announcement: Upexi plans to host a conference call on May 12, 2026, to report its financial results for Q3 2026, emphasizing the company's commitment to transparency and investor communication.
- Call Details: The call will begin at 5:30 p.m. ET, with participants able to dial in using the U.S. toll-free number 1-877-407-9716 or the international number 1-201-493-6779, ensuring easy access for investors to the latest company updates.
- Replay Availability: For those unable to join live, a replay of the call will be available until May 26, 2026, accessible via the U.S. toll-free number 1-844-512-2921 or the international number 1-412-317-6671, reflecting the company's attentiveness to investor needs.
- Digital Asset Strategy: Upexi focuses on holding over two million SOL in a disciplined manner, employing mechanisms like intelligent capital issuance, staking, and discounted locked token purchases, showcasing its strategic positioning and adaptability in the digital asset market.
- Financial Performance Overview: Upexi reported total revenue of approximately $8.1 million for Q2, an increase of about $4 million year-over-year, despite a net loss of approximately $178.9 million primarily due to unrealized losses on digital assets and stock compensation expenses, indicating financial pressure amid market volatility.
- Asset Management Strategy: CEO Allan Marshall emphasized that despite a 40% drop in Solana prices, the company plans to enhance its valuation by increasing Solana token holdings and yields, demonstrating a commitment to stability in uncertain markets.
- Market Risk Mitigation: Management identified market volatility and declining Solana prices as key risks impacting quarterly results, with Marshall mentioning mergers and asset sales as potential mitigants, reflecting the company's adaptive strategies in the face of challenges.
- Future Outlook: Although no specific earnings guidance was provided, management remains optimistic about Solana's long-term potential, planning to increase the number of tokens held in treasury and boost quarterly revenue from the treasury, indicating confidence in market recovery.








